Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model

Background/Aim: Dedifferentiated liposarcoma (DDLPS) is recalcitrant type of sarcoma. DDLPS has a low survival rate with high recurrence and metastasis. In the present study, we evaluated the efficacy of several drugs against doxorubicin-resistant DDLPS in a patient-derived orthotopic xenograft (PDO...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Genomics Proteomics
Glavni autori: IGARASHI, KENTARO, KAWAGUCHI, KEI, KIYUNA, TASUKU, MIYAKE, KENTARO, HIGUCHI, TAKASHI, YAMAMOTO, NORIO, HAYASHI, KATSUHIRO, KIMURA, HIROAKI, MIWA, SHINJI, SINGH, SHREE RAM, TSUCHIYA, HIROYUKI, HOFFMAN, ROBERT M
Format: Artigo
Jezik:Inglês
Izdano: International Institute of Anticancer Research 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7367606/
https://ncbi.nlm.nih.gov/pubmed/32576580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20194
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items